A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods

Launched by UNIVERSITY OF SYDNEY · Nov 24, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to deliver radiation therapy for cancer patients called Real-Time Image Guided Radiation Therapy (IGRT). The main goal is to see if this method can be effectively used to target tumors during treatment. Researchers want to find out if they can deliver all planned doses of radiation on schedule, if the radiation can accurately hit the tumor at least 85% of the time, and if there are any serious side effects.

To participate, you need to be at least 18 years old and scheduled to receive radiation therapy for certain types of cancer, including brain, breast, or lung cancer, among others. You should also be in fairly good health and able to understand the study. If you join, you won't need any extra treatments or preparations beyond what you would normally have for radiation therapy. This trial is not yet recruiting participants, so if you're interested, keep an eye out for updates!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients 18 years or older to be treated with curative radiation therapy
• • Patients with brain, breast, head and neck, kidney, liver, lung, pancreas, prostate or spine cancer
• • ECOG performance status 0-2
• • Ability to understand and the willingness to sign a written informed consent document
• Exclusion Criteria:
• • Pregnancy,
• • Patients with any other clinically significant medical condition which, in the opinion of the treating physician, makes it undesirable for the patient to participate in the study or which could jeopardize compliance with study requirements or severe psychiatric illness/social situation
• • Additional inclusion and exclusion criteria may apply to a specific sub-study